SCHEMBL5719364

SCHEMBL5719364

C=CCN1c2c(n(C)c(=O)n(CC)c2=O)N(OC(=O)C(F)(F)F)C1N1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5718947 0.95
SCHEMBL5719332 0.92 KDM4E (0.31)
SCHEMBL5719033 0.91 DPP4 (0.34)
SCHEMBL5719117 0.90
SCHEMBL5718841 0.89 DPP4 (0.33)
SCHEMBL5719674 0.88 DPP4 (0.35)
SCHEMBL5718809 0.87 DPP4 (0.37)
SCHEMBL5719708 0.85 DPP4 (0.34)
SCHEMBL5719084 0.85 DPP4 (0.36)
SCHEMBL5718875 0.85 DPP4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7074798-B2 Xanthine derivative and DPPIV inhibitor EISAI CO., LTD (JP) 2006-07-11 US disclosed
EP-1338595-B1 Xanthine derivatives as DPP-IV inhibitors EISAI CO LTD (JP) 2006-05-03 EP disclosed
US-20040082570-A1 Xanthine derivative and DPPIV inhibitor EISAI CO., LTD. (JP) 2004-04-29 US disclosed
EP-1338595-A2 Xanthine derivatives as DPP-IV inhibitors Eisai Co., Ltd. (JP) 2003-08-27 EP disclosed